Neuropsychiatric symptoms in at-risk groups for AD dementia and their association with worry and AD biomarkers—results from the DELCODE study

Saved in:
Bibliographic Details
Published inAlzheimer's Research & Therapy Vol. 12
Main Authors Claudia Bartels, Matthias H. J. Munk, Jens Wiltfang, Janna Rudolph, Michael Wagner, Ann-Katrin Schild, Robert Perneczky, Alexandra Polcher, Emrah Duezel, Frederic Brosseron, Slawek Altenstein, Oliver Peters, Stefan J. Teipel, Wenzel Glanz, Daniel Janowitz, Christina Rösch, Anja Schneider, Ingo Kilimann, Christoph Laske, Katharina Buerger, Lena Sannemann, Nicoleta Carmen Cosma, Eike Jakob Spruth, Frank Jessen, Annika Spottke, Boris Rauchmann, Coraline D. Metzger, Steffen Wolfsgruber, Klaus Fliessbach, Josef Priller, Silka Dawn Freiesleben, Michael T. Heneka, Ruth Vukovich, Xenia Kobeleva
Format Journal Article
LanguageJapanese
Published Springer Science and Business Media LLC 16.10.2020
Subjects
Aged
Alzheimer Disease
Alzheimer’s disease
Amyloid
Anxiety
Biomarkers
Cognitive Dysfunction
Cognitive Dysfunction/epidemiology [MeSH] ; Subjective cognitive decline ; Aged [MeSH] ; Anxiety/epidemiology [MeSH] ; Alzheimer Disease/epidemiology [MeSH] ; Humans [MeSH] ; Longitudinal Studies [MeSH] ; Alzheimer’s disease ; Amyloid ; Neuropsychiatric symptoms ; Research ; Biomarkers [MeSH] ; Neuropsychological Tests [MeSH]
ddc:610
ddc:no
epidemiology [Alzheimer Disease]
epidemiology [Anxiety]
epidemiology [Cognitive Dysfunction]
Humans
Longitudinal Studies
Neurology. Diseases of the nervous system
Neuropsychiatric symptoms
Neuropsychological Tests
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
RC346-429
Subjective cognitive decline
Online AccessGet full text

Cover

More Information
ISSN:1758-9193
DOI:10.1186/s13195-020-00701-7